ADC Conjugation Chemistry Service

Creative Biolabs provides high-precision ADC conjugation services that bridge the gap between antibody development and advanced biochemical applications. We provide end-to-end support, including specialized linker-payload design, optimized conjugation protocols, and rigorous analytical verification. Our clients can expect to gain access to highly homogeneous conjugates with verified drug-to-antibody ratios (DAR), reduced aggregation, and enhanced structural stability. By utilizing our platform, researchers obtain high-quality molecular entities that provide clear, reproducible data for complex biochemical assays and early-stage discovery pipelines.

Introduction What We Can Offer How We Can Help Why Choose Us? Customer Reviews FAQs Related Services Contact Us

Comprehensive ADC Conjugation Chemistry Services: Site-Specific Solutions

For a complete ADC, the antibody is the key component to determine the target specificity with the capability to deliver the cytotoxic payload. Via a wide range of conjugation chemistry, the payload drugs can be attached to various sites on an antibody. Antibody conjugation can be generated by: natural amino acids; interchain disulfides; engineered cysteines; non-natural amino acids; carbohydrate moiety; N-terminus of heavy and light chain; engineered tags; strong protein-protein interaction such as Fc-binding domains which can be used to form non-covalent antibody conjugates; nucleotide binding site which is a valuable antibody modification site for photoaffinity labeling; antibodies with catalytic activity can be developed to form bioconjugates.

We offer various solutions for multiple potential conjugation sites of endogenous amino acids. In addition, we provide special moieties conjugation engineering services to achieve more precise site-directed conjugations and a narrower distribution of DAR.

Request a Consultation →

Fig.1 ADC structure and mechanism of action overview. (OA Literature)Fig.1 Structure and Mechanism of Action of ADC. 1

What We Can Offer

ADC Conjugation Methods

Creative Biolabs offers near-physiological conditions to perform ADC conjugation reactions to ensure antibody bioactivity. With senior scientists and technicians, we established several platforms, including endogenous amino acids and other sites, especially lysine conjugation, cysteine conjugation, and tyrosine conjugation.

Method Advantages Disadvantages Applications
Lysine Conjugation High payload loading Heterogeneous DAR Broad applicability
Cysteine Conjugation Stable and site-specific Requires reduction Homogeneous ADCs
Tyrosine Conjugation Minimal off-target modifications Limited tyrosine residues Specialized designs
Enzymatic Conjugation Exceptional precision Enzyme-substrate dependency Homogeneous, advanced ADCs

ADC Design and Engineering Services

Creative Biolabs offers advanced methodologies for antibody design and engineering, enabling the introduction of precise and chemically versatile conjugation sites to optimize antibody-drug conjugates (ADCs). To achieve a consistent and narrower drug-to-antibody ratio (DAR), our solutions include:

Thiol-Engineered Antibodies

Enhancing conjugation efficiency by engineering thiol groups at targeted sites.

Unnatural Amino Acids

Genetic incorporation of residues like p-Acetyl Phenylalanine for site-specific conjugation.

Enzyme-Mediated Modifications

Utilizing enzymes such as transglutaminases and formylglycine-generating enzymes for precise site modifications.

Meditope-Based Conjugations

Creating specific binding cavities to enable controlled payload attachment.

Intein-Fusion Antibodies

Facilitating modular and seamless payload conjugation through intein-based engineering.

N-Glycan Engineering

Modifying glycan moieties for site-directed drug attachment.

How Creative Biolabs' service Can Assist Your Projects

Core steps of ADC conjugation chemistry service. (Creative Biolabs Original)

Highlights

Expert Synergy

We combine deep biological insights with chemical precision, providing a unique hybrid approach that standard providers often lack during development.

Biological Intuition

Our team analyzes how payload attachment influences the antibody's isoelectric point (pI) and critical biochemical characteristics for better performance.

Service Features

Superior Index

Supported by Published Data, our site-specific conjugates demonstrate a multi-fold increase in molecular stability over traditional stochastic conjugation methods.

Platform Validation

We utilize a validated platform to ensure every conjugate meets rigorous standards for homogeneity, stability, and predictable research performance.

Discover how we can help - Get a quote today.

Customer Reviews

FAQs

What is DAR, and why is it important?

DAR (drug-to-antibody ratio) determines the number of payload molecules attached to each antibody. An optimized DAR ensures balanced efficacy and safety, reducing toxicity and maximizing therapeutic windows.

How does Creative Biolabs ensure site-specific conjugation?

Our advanced methodologies, including enzymatic conjugations and engineered antibodies, precisely target desired conjugation sites, minimizing off-target modifications.

Related Services

Linker and Payload Synthesis Service

We provide custom synthesis of high-purity payloads and innovative linkers, including cleavable and non-cleavable options for specialized discovery and development applications.

Learn More →

ADC Analytical Characterization and Validation

We offer comprehensive biochemical validation, including drug-load distribution, purity analysis, and thermal stability assessments, to ensure consistent molecular performance across discovery projects.

Learn More →

How to Contact Us

An appropriate conjugation design and chemistry are critically important for the success of an ADC product. With advanced antibody design platforms and solutions, Creative Biolabs is dedicated to being your best companion in producing customized ADCs tailored to best fit your project. We are committed to maximizing your success. For more information or a detailed quote, please feel free to contact us.

Reference

  1. Tsuchikama, Kyoji, and Zhiqiang An. "Antibody-drug conjugates: recent advances in conjugation and linker chemistries." Protein & cell vol. 9,1 (2018): 33-46. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1007/s13238-016-0323-0
Loading case studies...
Online Inquiry